Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : firstname.lastname@example.org
AGL2043 inhibits the tyrosine kinase activity of PDGFRA, PDGFRB, KIT, and FLT3, which may inhibit growth and promote apoptosis in cancer (PMID: 12670652).
|DrugClasses||FLT3 Inhibitor 61 KIT Inhibitor 55 PDGFR Inhibitor (Pan) 28|
|CAS Registry Number||22617-28-8|
|Therapy Name||Drugs||Efficacy Evidence||Clinical Trials|